Novo Nordisk Objects To Expert In ITC Drug Patent Row
Danish pharmaceutical company Novo Nordisk A/S objected to sharing confidential business information with a technical expert witness linked to a major competitor on Wednesday, saying the move would be highly prejudicial...To view the full article, register now.
Already a subscriber? Click here to view full article